Award
NIH Reporter #11264765
Novel Disease-modifying Small Molecules for Treatment of Alzheimer's Disease
Recipient
MINNEAPOLIS VA MEDICAL CENTER
Awarded
January 07, 2026
Identifier
11264765
Award for research on small molecules targeting synaptojanin 1 for Alzheimer's disease, aiming to enable IND studies and progress to clinical trials.
Description
This project involves IND-enabling studies for small molecules targeting synaptojanin 1 (synj1) for Alzheimer's disease, including pharmacological, toxicology, and biomarker development studies, with the goal of transitioning into clinical trials and commercialization.